Drug Trial Radar · NCT00911937
A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency
Last checked: Nov 20, 2026Latest source record: Dec 4, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
963
Actual
Start
Aug 2009
Primary completion
Sep 2011
Study completion Sep 2011
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jun 3, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to assess the efficacy of a flexible dose regimen of fesoterodine on micturition related nocturnal urgency episodes.
Conditions
- Overactive Bladder
Interventions
FesoterodineDrug
Fesoterodine 4mg and 8 mg tablets taken daily.
PlaceboDrug
Placebo sham 4mg and 8 mg tables taken daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Number of Micturition-related Nocturnal Urgency Episodes Per 24 HoursTime frame: Baseline
- Change From Baseline in Mean Number of Micturition-related Nocturnal Urgency Episodes Per 24 Hours at Week 12Time frame: Baseline and Week 12
Locations
112 sites in 1 country. Site status is shown where the registry gives one.
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Goodyear, Arizona
Pfizer Investigational Site
Litchfield Park, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Little Rock, Arkansas
Pfizer Investigational Site
Fresno, California
Pfizer Investigational Site
La Mesa, California
Pfizer Investigational Site
Newport Beach, California
Pfizer Investigational Site
Roseville, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Tarzana, California
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Farmington, Connecticut
Pfizer Investigational Site
New Britain, Connecticut
Pfizer Investigational Site
Norwalk, Connecticut
Pfizer Investigational Site
Dover, Delaware
Pfizer Investigational Site
Bonita Springs, Florida
Pfizer Investigational Site
Brooksville, Florida
Pfizer Investigational Site
DeFuniak Springs, Florida
Pfizer Investigational Site
Destin, Florida
Pfizer Investigational Site
Leesburg, Florida
Pfizer Investigational Site
Naples, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Pembroke Pines, Florida
Pfizer Investigational Site
South Miami, Florida
Pfizer Investigational Site
St. Petersburg, Florida
Pfizer Investigational Site
Tallahassee, Florida
Pfizer Investigational Site
Tampa, Florida
Pfizer Investigational Site
Atlanta, Georgia
Pfizer Investigational Site
Coeur d'Alene, Idaho
Pfizer Investigational Site
Chicago, Illinois
Pfizer Investigational Site
Chicago, Illinois
Pfizer Investigational Site
Fort Wayne, Indiana
Pfizer Investigational Site
Jeffersonville, Indiana
Showing 40 of 112 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.